Phone(703) 698-8960
Fax(877) 310-6768
Verity HQ3028 Javier Road
Fairfax, VA 22031
Office Hours:Mon - Fri : 8:00 am - 4:30
Sat - Sun : CLOSED
Phone(703) 698-8960
Fax(877) 310-6768
Verity HQ3028 Javier Road
Fairfax, VA 22031
Office Hours:Mon - Fri : 8:00 am - 4:30
Sat - Sun : CLOSED

Our Studies

Verity Research, Inc. Current and Upcoming Trials

CONDITION

STUDY NAME

BASIC CRITERIA

Crohn’s Disease (Enrolling)

Trident Study: Injectable Medication

  • Moderate to severe symptoms
  • Failed conventional therapy or inadequate response to ≥ 1 biologic therapies (NO STELARA)

Ulcerative Colitis (Enrolling)

Vibrato: Oral Medication

  • Moderate to severe symptoms
  • Failed conventional therapy or inadequate response to 1 of the following conventional treatments: Steroids, AZA, 6-MP, MTX, Anti-TNF Inhibitors, Anti-Integrin Inhibitors
  • Can be on stable treatment with 5-ASA or oral corticosteroid

NASH (Now Open!)

Stellar-3: Oral Medication

  • Liver biopsy with NASH- F3 fibrosis
  • Ok if existing dx of NASH

NASH (Now Open!)

Stellar-4: Oral Medication

  • Liver biopsy with NASH- F4 fibrosis (Cirrhosis)
  • Platelet > 100k

NASH (Now Open!)

Aurora: Oral Medication

  • Liver biopsy with NASH- F2 & F3 fibrosis
  • Platelet > 100k, T. Bili < 1.5 mg/dL – Gilbert’s syndrome may still be eligible

H. Pylori NASH (Opening November!)

Eradicate Hp2: Oral Medication

  • H. Pylori eradication therapy naïve
  • Non-Asian Males & Females having symptoms consistent with dyspepsia of at least 2 weeks duration